These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7184943)

  • 1. Inhibition of mixed-function oxidase activities in vitro and in vivo: comparisons between kidney and liver.
    Kluwe WM; Herrmann-Kluwe CL; Hook JB
    J Appl Toxicol; 1982 Oct; 2(5):226-30. PubMed ID: 7184943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative induction of xenobiotic metabolism in rodent kidney, testis and liver by commercial mixtures of polybrominated biphenyls and polychlorinated biphenyls, phenobarbital and 3-methylcholanthrene: absolute and temporal effects.
    Kluwe WM; Hook JB
    Toxicology; 1981; 20(2-3):259-73. PubMed ID: 6266081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitor panel studies of human hepatic and placental cytochrome P-450-associated monooxygenase activities.
    Pasanen M; Taskinen T; Sotaniemi EA; Kairaluoma M; Pelkonen O
    Pharmacol Toxicol; 1988 May; 62(5):311-7. PubMed ID: 3413034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of hepatic aryl hydrocarbon hydroxylase activity in feral winter flounder: relevance to carcinogenicity testing.
    Bend JR; Foureman GL; Ben-Zvi Z; Albro PW
    Natl Cancer Inst Monogr; 1984 May; 65():359-70. PubMed ID: 6462197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of hepatic mixed-function oxidases. 4. Effects of benzimidazole and related compounds on aryl hydrocarbon hydroxylase activity from phenobarbitone and 3-methylcholanthrene induced rats.
    Little PJ; Ryan AJ
    J Med Chem; 1982 Jun; 25(6):622-6. PubMed ID: 7097715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of medicarpin and related isoflavonoids in inhibition of rat hepatic mixed function oxidase activity.
    Friedman FK; West D; Dewick PM; Gelboin HV
    Pharmacology; 1985; 31(5):289-93. PubMed ID: 3877941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cimetidine: a specific inhibitor of hepatic aryl hydrocarbon hydroxylase (AHH) in the rat.
    Drew R; Rowell J; Grygiel JJ
    Res Commun Chem Pathol Pharmacol; 1981 Jul; 33(1):81-93. PubMed ID: 7268211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential sensitivity of hepatic microsomal aryl hydrocarbon hydroxylase to the inhibitory effect of SKF 525-A in rats of varying age, hormonal- and drug-induced status.
    Gontovnick LS; Bellward GD
    Can J Physiol Pharmacol; 1982 Aug; 60(8):1083-8. PubMed ID: 7127220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered activities of hepatic and extrahepatic microsomal mixed function oxidase enzymes in diabetic and adrenalectomized diabetic rats.
    Al-Turk WA; Stohs SJ; Roche EB
    Pharmacology; 1981; 23(6):337-45. PubMed ID: 6975948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism.
    Atal CK; Dubey RK; Singh J
    J Pharmacol Exp Ther; 1985 Jan; 232(1):258-62. PubMed ID: 3917507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of benzo[a]pyrene hydroxylase and epoxide hydrolase derived from isolated rat hepatic nuclei and microsomes.
    Gontovnick LS; Bellward GD
    Drug Metab Dispos; 1981; 9(3):265-9. PubMed ID: 6113938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of inhibition of microsomal drug metabolism by imidazole.
    Hajek KK; Cook NI; Novak RF
    J Pharmacol Exp Ther; 1982 Oct; 223(1):97-104. PubMed ID: 7120133
    [No Abstract]   [Full Text] [Related]  

  • 13. Characteristics of aryl hydrocarbon hydroxylase activity in rat mammary epithlial cells grown in primary culture.
    Greiner JW; Malan-Shibley LB; Janss DH
    Chem Biol Interact; 1979 Oct; 27(2-3):323-34. PubMed ID: 115598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of polybrominated biphenyls, beta-naphthoflavone and phenobarbital on arylhydrocarbon hydroxylase activities and chloroform-induced nephrotoxicity and hepatotoxicity in male C57BL/6J and DBA/2J mice.
    Ahmadizadeh M; Kuo CH; Echt R; Hook JB
    Toxicology; 1984 Jun; 31(3-4):343-52. PubMed ID: 6330937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different responsiveness of hepatic and pulmonary microsomal mixed function oxidases to phenobarbital-type and 3-methylcholanthrene-type polychlorinated biphenyls in rats.
    Yoshihara S; Nagata K; Yoshimura H
    J Pharmacobiodyn; 1983 Dec; 6(12):954-62. PubMed ID: 6425489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the immunosuppressant FK-506 and its analog FK-520 on hepatic and renal cytochrome P450 mixed-function oxidase.
    Vincent SH; Wang RW; Karanam BV; Klimko M; Alvaro R; Chiu SH
    Biochem Pharmacol; 1991 May; 41(9):1325-30. PubMed ID: 1708254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of H2-receptor antagonists on cytochrome P450 in male ICR mice.
    Kim DH; Kim EJ; Han SS; Roh JK; Jeong TC; Park JH
    Hum Exp Toxicol; 1995 Aug; 14(8):623-9. PubMed ID: 7576828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of o-benzyl-p-chlorophenol on drug-metabolizing enzymes in rats.
    Kao LR; Goldstein JA; Birnbaum LS
    Biochem Pharmacol; 1986 Feb; 35(4):613-20. PubMed ID: 3947391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding to oxidised cytochromes P-450 and inhibition of mixed-function oxidases by aryl-substituted benzimidazoles and related compounds.
    Murray M; Ryan AJ
    Chem Biol Interact; 1983 Mar; 43(3):341-51. PubMed ID: 6825202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of house fly microsomal mixed function oxidases: inhibition by juvenile hormone i and piperonyl butoxide.
    Fisher CW; Mayer RT
    Toxicology; 1982; 24(1):15-31. PubMed ID: 6814016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.